Jyong Biotech Ltd. Ordinary Shares (MENS) — Net Asset Momentum
Jyong Biotech Ltd. Ordinary Shares (MENS) recorded a net asset momentum of -7.2% as of December 2024, with net assets of $-36.52 Million USD. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See MENS defensive asset coverage days to measure how many days the company can operate on defensive assets alone.
YoY Momentum
Current Net Assets
Years of Data
Country
Jyong Biotech Ltd. Ordinary Shares Net Asset Momentum (2020–2024)
This chart tracks Jyong Biotech Ltd. Ordinary Shares's year-over-year net asset growth across 5 annual reporting periods from 2020 to 2024. The most recent momentum reading is -7.2%, with net assets of $-36.52 Million USD as of December 2024. Read Jyong Biotech Ltd. Ordinary Shares balance sheet liabilities for a breakdown of total debt and financial obligations.
Annual Net Asset History for Jyong Biotech Ltd. Ordinary Shares (2020–2024)
The table below shows the complete annual net asset history for Jyong Biotech Ltd. Ordinary Shares from 2020 to 2024, covering 5 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see MENS market cap overview.
| Year | Net Assets (USD) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2024 | $-36.52 Million | $6.37 Million | $42.88 Million | ▼ -7.2% |
| 2023 | $-34.07 Million | $8.25 Million | $42.32 Million | ▼ -15.0% |
| 2022 | $-29.63 Million | $8.74 Million | $38.38 Million | ▼ -27.0% |
| 2021 | $-23.32 Million | $9.43 Million | $32.76 Million | ▼ -21.5% |
| 2020 | $-19.20 Million | $12.84 Million | $32.05 Million | — |